CopyMark Law Group
4.9/5
Drawing for EVIVE

USPTO serial 79295058

EVIVE

Reviewed by CopyMark Law Group

Reg. 6488611Status 700Renewal
Filing date
Status date
Registration date
Sep 21, 2021
Examiner
STIGLITZ, SUSAN R
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EVIVE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $975

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa W. Rosaya

Lisa W. Rosaya Baker & McKenzie LLP452 Fifth AvenueNEW YORK, NY 10018UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals, medical and veterinary preparations, namely, preparations for the treatment of infectious disease and for use in oncology, diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans, pharmaceutical preparations for use in chemotherapy, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical preparations for the treatment of viral infections and diseases, and antibacterial pharmaceuticals; pharmaceutical preparations for health care, namely, anti-inflammatory preparations, antipyretic preparations, biological preparations for the treatment of cancer, mixed biological preparations for the treatment and prevention of infectious diseasesACTIVE—
010Apparatus for medical use, namely, insulin pumps, insulin injectors sold empty, medical fluid injectorsACTIVE—
042Research and development services relating to medicines; medical laboratory services; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; design of medical apparatus for others; biotechnology research; research relating to pharmaceuticalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 21, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 18, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 7, 2022XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Mar 7, 2022XXCRGENERIC MADRID TRANSACTION CREATED—
Dec 21, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 21, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 19, 2021GPNXNOTIFICATION PROCESSED BY IB—
Jul 6, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 6, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 30, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 30, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 16, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 28, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 12, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 11, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 11, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2021ATRVATTORNEY REVIEW COMPLETED—
Mar 25, 2021CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED—
Mar 20, 2021CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Mar 5, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB—
Dec 6, 2020RFNTREFUSAL PROCESSED BY IB—
Nov 11, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 11, 2020RFRRREFUSAL PROCESSED BY MPU—
Oct 21, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 20, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 19, 2020DOCKASSIGNED TO EXAMINER—
Oct 17, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 13, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 8, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance